Inventor · disambiguated record
Teruyuki Sakai
Also filed as: SAKAI TERUYUKI
11 granted patents·2 pending applications·588 citations·filing 1991–2006
93Inventor score
Top patents by PatentIndex Score
13 records- 0194US6821987B2Quinoline derivatives and quinazoline derivatives having azolyl groupKIRIN BREWERY·Filed 2002·Granted Nov 23, 2004·93 cites·57 claims
- 0291US7495104B2Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptorsKIRIN BREWERY·Filed 2002·Granted Feb 24, 2009·55 cites·21 claims
- 0391US7135466B2Quinoline and quinazoline derivatives and drugs containing the sameKIRIN BREWERY·Filed 2000·Granted Nov 14, 2006·86 cites·30 claims
- 0491US5936076Aαgalactosylceramide derivativesKIRIN BREWERY·Filed 1995·Granted Aug 10, 1999·179 cites·60 claims
- 0588US7211587B2Quinoline derivatives and quinazoline derivatives having azolyl groupKIRIN BREWERY·Filed 2004·Granted May 1, 2007·35 cites·33 claims
- 0685US6750255B2Calcium receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Jun 15, 2004·19 cites·31 claims
- 0784US5416066A1,4-benzothiazepine derivativesKANEKO NOBORU·Filed 1991·Granted May 16, 1995·36 cites·19 claims
- 0883US6362231B1Calcium receptor active compoundsNPS PHARMA INC·Filed 1997·Granted Mar 26, 2002·45 cites·30 claims
- 0979US6939895B2Calcium receptor-active compoundsNPS PHARMA INC·Filed 2002·Granted Sep 6, 2005·10 cites·20 claims
- 1062US5461036ASpicamycin derivatives and their use as anticancer agentsKIRIN BREWERY·Filed 1992·Granted Oct 24, 1995·15 cites·21 claims
- 1156US5631238ASpicamycin derivatives and the use thereofKIRIN BREWERY·Filed 1995·Granted May 20, 1997·15 cites·16 claims
- 1255US2006211717A1Quinoline and quinazoline derivatives and drugs containing the sameKIRIN BREWERY·Filed 2006·Application pending·0 cites
- 1353US2003176485A1Calcium receptor active compoundsNPS PHARMA INC·Filed 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Teruyuki Sakai files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →